Dr. Feller-Kopman serves as the Director of Bronchoscopy and Interventional Pulmonology at Johns Hopkins. He is an expert in the minimally invasive diagnosis and staging of lung cancer. His areas of clinical expertise include all aspects of interventional pulmonology, including minimal invasive diagnostic procedures to evaluate suspicious lung nodules and enlarged lymph nodes in the chest as well as the evaluation and management of malignant and non-malignant central airway obstruction. In addition, he specializes in the evaluation and management of pleural diseases with minimally invasive procedures such as ultrasound guided thoracentesis, indwelling pleural catheters and thoracoscopy with pleurodesis. He is a fellow of the American College of Chest Physicians and the American Thoracic Society, as member of the Miller-Coulson academy of Clinical Excellence at Johns Hopkins.
Dr. Feller-Kopman’s research focuses on the minimally invasive treatment of patients with malignant pleural effusion. Dr. Feller-Kopman co-founded the Interventional Pulmonary Outcomes Group (IPOG) whose mission is to provide and support multicenter prospective trials in the Interventional Pulmonary space. He is also involved with several projects investigating minimally invasive ways to diagnose and treat lung cancer. His goal is to advance the science of Interventional Pulmonology in order to improve the quality of life of patients with malignant pleural effusions and central airway obstruction as well as to develop new strategies to diagnosis and treat lung cancer.
He completed his internship and residency at Beth Israel Hospital, Harvard University; a Fellowship in Pulmonary and Critical Care, Combined Harvard Program (Massachusetts General Hospital, Brigham and Women’s Hospital, Beth Israel Deaconess Medical Center; and a Fellowship: Interventional Pulmonary, Beth Israel Deaconess Medical Center, Harvard University. He is board certified in Internal Medicine, Pulmonary Disease, Critical Care Medicine, and Interventional Pulmonary.
